IL - 18 テトラペプチド配列に基づくカスパース−8の強力な阻害剤は,炎症およびアポプトシスイニシアターカスパースの共通の特異性を明らかにする
Christopher M Bourne1, Nicole R Raniszewski1, Ashutosh B Mahale1
1Department of Biochemistry and Biophysics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.
ACS bio & med chem Au
|August 27, 2025
まとめ
研究者は,炎症と細胞死における重要な酵素であるカスパース8を標的とした新しいペプチド阻害剤を開発しました. このLESDベースの阻害剤は,既存の選択肢よりも強力で,カスパスを研究するための改善されたツールを提供します.
科学分野:
- 生物化学
- 分子生物学
- 免疫学
背景:
- カスパスは細胞死と炎症を調節するシステインタンパク質です.
- 特定のカスパース基板と選択性の要因を特定することは極めて重要です.
- 炎症性カスパス (1, 4, 5) はIL-1βとIL-18を分割する.
研究 の 目的:
- カスパスの新しいペプチドベースの探査機と阻害剤を開発する.
- 新しいカスパース阻害剤と既存のカスパース阻害剤の選択性と効能を記述する.
- 感染時のカスパース8の活性化を調べる
主な方法:
- IL - 18 テトラペプチド配列 (LESD) に基づくペプチド阻害剤を設計した.
- IC50値を用いて抑制剤の効能と選択性を評価した.
- 感染時の骨髄由来原発マクロファージにおける抑制剤の有効性を評価した.
- 既知のカスパース基板と阻害剤を体系的に特徴づけた.
主要な成果:
- LESDベースの阻害剤は,zIETD- FMKを上回る高選択性 (IC50 = 50 nM) を示した.
- この阻害剤は感染中にマクロファージのカスパース8活性化を効果的に阻害した.
- カスパース-1と-4の阻害剤であるVX-765は,カスパース-8も阻害する (IC50=1μM).
- カスパスは,共有された基板と阻害剤に対して,異なる効率と効能を示す.
結論:
- 強力で選択的な LESD ベースのカスパース-8 阻害剤の開発
- カスパスの生物学的な役割の研究には 新しいツールが利用できます
- カスパースの選択性と効能を理解することは,薬の開発に極めて重要です.
関連する概念動画
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...


